Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07733817) titled 'Impact of Probiotics on Neuropathy Induced by Adjuvant Chemotherapy in Patients With Colon Cancer' on July 24.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Triple (Participant, Care Provider, Investigator).
Primary Sponsor: Centre Francois Baclesse
Condition:
Colon Adenocarcinoma
Neuropathic Pain
Intervention:
Dietary Supplement: PROBIOTIC SUPPLEMENTATION BY OXXYSLAB(R)
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: October 1, 2026
Target Sample Size: 130
Countries of Recruitment:...